Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 21

1.
2.

Distinct and complementary roles for α and β isoenzymes of PKC in mediating vasoconstrictor responses to acutely elevated glucose.

Jackson R, Brennan S, Fielding P, Sims MW, Challiss RA, Adlam D, Squire IB, Rainbow RD.

Br J Pharmacol. 2016 Mar;173(5):870-87. doi: 10.1111/bph.13399. Epub 2016 Feb 8.

3.

Hypoglycemia in Non-diabetics During Development of Acute Coronary Ischemia.

Novakovic A, Zukic E, Gazibera B, Gojak R.

Med Arch. 2015 Aug;69(4):226-8. doi: 10.5455/medarh.2015.69.226-228. Epub 2015 Aug 4.

4.

Diabetes mellitus and glucose as predictors of mortality in primary coronary percutaneous intervention.

David RB, Almeida ED, Cruz LV, Sebben JC, Feijó IP, Schmidt KE, Avena LM, Gottschall CA, Quadros AS.

Arq Bras Cardiol. 2014 Oct;103(4):323-30. Epub 2014 Sep 12. English, Portuguese.

5.

Diabetes increases mortality after myocardial infarction by oxidizing CaMKII.

Luo M, Guan X, Luczak ED, Lang D, Kutschke W, Gao Z, Yang J, Glynn P, Sossalla S, Swaminathan PD, Weiss RM, Yang B, Rokita AG, Maier LS, Efimov IR, Hund TJ, Anderson ME.

J Clin Invest. 2013 Mar;123(3):1262-74. doi: 10.1172/JCI65268. Epub 2013 Feb 15. Erratum in: J Clin Invest. 2013 May 1;123(5):2333.

6.

Glycemic Control during Coronary Artery Bypass Graft Surgery.

Lazar HL.

ISRN Cardiol. 2012;2012:292490. doi: 10.5402/2012/292490. Epub 2012 Nov 14.

7.

Is admission blood glucose concentration a more powerful predictor of mortality after myocardial infarction than diabetes diagnosis? A retrospective cohort study.

Gholap NN, Mehta RL, Ng L, Davies MJ, Khunti K, Squire IB.

BMJ Open. 2012 Sep 25;2(5). pii: e001596. doi: 10.1136/bmjopen-2012-001596. Print 2012.

8.

Admission hyperglycemia and acute myocardial infarction: outcomes and potential therapies for diabetics and nondiabetics.

Chakrabarti AK, Singh P, Gopalakrishnan L, Kumar V, Elizabeth Doherty M, Abueg C, Wang W, Gibson CM.

Cardiol Res Pract. 2012;2012:704314. doi: 10.1155/2012/704314. Epub 2012 Jul 9.

9.

How to best manage glycemia and non-glycemia during the time of acute myocardial infarction.

Hirsch IB, O'Brien KD.

Diabetes Technol Ther. 2012 Jun;14 Suppl 1:S22-32. doi: 10.1089/dia.2012.0095. Review.

10.

Insulin therapy for the management of hyperglycemia in hospitalized patients.

McDonnell ME, Umpierrez GE.

Endocrinol Metab Clin North Am. 2012 Mar;41(1):175-201. doi: 10.1016/j.ecl.2012.01.001. Epub 2012 Feb 17. Review.

11.

Piloting a novel algorithm for glucose control in the coronary care unit: the RECREATE (REsearching Coronary REduction by Appropriately Targeting Euglycemia) trial.

Nerenberg KA, Goyal A, Xavier D, Sigamani A, Ng J, Mehta SR, Díaz R, Kosiborod M, Yusuf S, Gerstein HC; RECREATE Investigators..

Diabetes Care. 2012 Jan;35(1):19-24. doi: 10.2337/dc11-0706. Epub 2011 Nov 10.

12.

In patients with acute myocardial infarction, the impact of hyperglycemia as a risk factor for mortality is not homogeneous across age-groups.

Nicolau JC, Serrano CV Jr, Giraldez RR, Baracioli LM, Moreira HG, Lima F, Franken M, Kalil R, Ramires JA, Giugliano RP.

Diabetes Care. 2012 Jan;35(1):150-2. doi: 10.2337/dc11-1170. Epub 2011 Oct 25.

13.

Relationship between admitting nonfasting blood glucose and in-hospital mortality stratified by diabetes mellitus among acute coronary syndrome patients in oman.

Panduranga P, Sulaiman K, Al-Lawati J, Al-Zakwani I.

Heart Views. 2011 Jan;12(1):12-7. doi: 10.4103/1995-705X.81554.

14.

Management of hyperglycemia in hospitalized patients.

Smiley D, Umpierrez GE.

Ann N Y Acad Sci. 2010 Nov;1212:1-11. doi: 10.1111/j.1749-6632.2010.05805.x. Epub 2010 Oct 29. Review.

15.

A meta-analysis of glucose-insulin-potassium therapy for treatment of acute myocardial infarction.

Mamas MA, Neyses L, Fath-Ordoubadi F.

Exp Clin Cardiol. 2010 Summer;15(2):e20-4.

16.

An overview of glycemic control in the coronary care unit with recommendations for clinical management.

Kosiborod M, Deedwania P.

J Diabetes Sci Technol. 2009 Nov 1;3(6):1342-51. Review.

17.

Near-normal glycemia for critically ill patients receiving nutrition support: fact or folly.

Reeds D.

Curr Opin Gastroenterol. 2010 Mar;26(2):152-5. doi: 10.1097/MOG.0b013e32833663af. Review.

18.

Clinical predictors of late death in survivors of acute myocardial infarction.

Agarwal SK, Singla I, Hreybe H, Saba S.

Tex Heart Inst J. 2009;36(1):24-30.

19.

American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control.

Moghissi ES, Korytkowski MT, DiNardo M, Einhorn D, Hellman R, Hirsch IB, Inzucchi SE, Ismail-Beigi F, Kirkman MS, Umpierrez GE; American Association of Clinical Endocrinologists.; American Diabetes Association..

Diabetes Care. 2009 Jun;32(6):1119-31. doi: 10.2337/dc09-9029. Epub 2009 May 8. No abstract available.

20.

Insulin therapy in acute coronary syndromes: an appraisal of completed and ongoing randomised trials with important clinical end points.

Goyal A, Nerenberg K, Gerstein HC, Umpierrez G, Wilson PW.

Diab Vasc Dis Res. 2008 Nov;5(4):276-84. doi: 10.3132/dvdr.2008.040. Review.

Supplemental Content

Support Center